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SURVEILLANCE OF ASTHMA CONTROL IN AN URBAN PEDIATRIC 






Introduction: Asthma is the most prevalent chronic disease in children, 
disproportionately affecting children from racial or ethnic minority groups and low-
income families. Boston Medical Center’s Pediatric Primary Care Center serves these 
patient populations predominantly from the surrounding neighborhoods. It has been 
found that there are gaps in asthma care including diagnosing asthma in infants and 
young children, under-prescribing of preventive medication in all age groups, and 
variable management of children with poorly controlled asthma. In alignment with the 
accountable care organization model, health care professionals at BMC are using 
evidence-based care and population-based approaches to reduce asthma morbidity and 
thus improve the quality of life for patients with asthma and their families. 
 
Methods: A quality improvement initiative was conducted at BMC’s Pediatric Primary 
Care Center. The aim was to develop routine surveillance of asthma control for the clinic 
population in order to identify and intervene on patients who have poorly controlled 
asthma. The Asthma Control Test (ACT) and the Test for Respiratory and Asthma 
Control in Kids (TRACK) were adapted into practice as validated patient-parent-reported 
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tools to use to assess asthma control at all primary care office visits. Process measure 
included the percentage of visits with a documented asthma control testing in the 
electronic medical record. Outcome measures included (1) percentage of patients with 
poorly controlled asthma presenting to the clinic, as indicated by low ACT/TRACK 
scores, and (2) percentage of visits with a documented provider action in response to low 
ACT/TRACK scores. Iterative Plan, Do, Study, Act (PDSA) cycles optimized results; 
process and outcome measures were analyzed on run charts for trends.  
 
Results and Conclusions: Patient-centered strategies for visits and population-based 
systems to analyze outcomes are effective at delivering quality care for BMC’s pediatric 
asthma patient population. Following the implementation of routine asthma control 
screening in primary care, the percentage of visits with documented ACT/TRACK scores 
went from a baseline of 8% to 86%. Week to week variation was mostly attributed to 
higher patient visit volume beginning in the Fall season when epidemiologically there is a 
substantially increased frequency of asthma exacerbations in children. A median of 23% 
of patients report poorly controlled asthma during their visit. The percent of visits with 
documented provider action increased from 87% to 95% during this quality improvement 
initiative, indicating that patients were receiving targeted care needs including medication 
management and asthma education in response to low ACT/TRACK scores. However, 
consistent and timely delivery of preventive care services continues to be a challenge, 
particularly for a clinic serving high-risk, underserved, and culturally diverse patient 
populations.   
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 Asthma is the most common chronic disease of childhood affecting approximately 
1 in 12 children in the United States ages 0-17 years1. The World Health Organization 
estimates that this number has increased by more than 60% since the early 1980s2. 
Furthermore, asthma disproportionately affects children, individuals from racial or ethnic 
minority groups, and low-income families3–5 (Figure 1). Approximately 4 million 
children experience an asthma exacerbation annually, thereby limiting participation in 
usual activities and resulting in bed days, work and school absences, visits to the 
emergency department (ED), and hospital admissions1,6,7. Therefore, there is a significant 
burden of asthma in the United States, and researchers and clinicians have been tasked to 
implement different prevention and intervention strategies to improve the quality of life 





Figure 1: Current Asthma Prevalence by Demographic in the United States, Average 
Annual 2008-2010. The graph is comparing rates of prevalence by Age Group, Sex, 
Race, Ethnicity, and household income. Children, adult females, Blacks, Puerto Ricans, 
and low-income individuals are more likely to have asthma. (Modified from Centers for 
Disease Control and Prevention5). 
 
Population Demographics 
Boston, Massachusetts is a racially and ethnically diverse city with 16 distinct 
neighborhoods and a population of 667,137 in 201511. Children under 18 years old who 
are Black or Latino made up approximately 17% of all Boston residents that same year11. 
The Health of Boston 2016-2017 Report highlights a tremendous health disparity in 
asthma outcomes by race, ethnicity, and neighborhood. 24% of Boston high school 
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students report having doctor-diagnosed asthma11. From 2011-2015, the asthma ED visit 
rate in Boston among children ages 5-17 increased by 9%, and there were significantly 
more ED visits for Latino and Black patient populations, see Table 111.  
 
Table 1: Emergency Department (ED) Visit Rate for Asthma per 10,000 children ages 5-
17 years old in Boston, by Race and Ethnicity, in 2015. There were significantly more 
ED visits for Latino and Black patient populations in comparison to White and Asian 
populations. (Modified from Health of Boston 2016-2017 Report11)  
Race/Ethnicity ED Visit Rate per 10,000 children 







Boston Medical Center’s Pediatric Primary Care 
Located in the South End neighborhood, Boston Medical Center (BMC) is a 
private, not-for-profit, academic medical center. BMC is the largest safety net hospital in 
New England, with a majority of patients from underserved populations and 32% of 
patients do not speak English as a primary language12. The 2010 census data reports the 
majority of Black residents live in BMC’s surrounding neighborhoods11. The Pediatric 
Primary Care Center, co-located with emergency and specialty care services at the 
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hospital, provides comprehensive health care including urgent care and preventative 
medicine for approximately 13,000 patients ages 0-26 years old and predominately serves 
populations from Dorchester, Roxbury, and Mattapan (Figure 2).  
 
Figure 2: Map of neighborhoods surrounding BMC, by Race and Ethnicity. BMC’s 
Pediatric Primary Care serves predominately patients living in Dorchester (DOR), 
Roxbury (RX), and Mattapan (MT). Majority Black resident census tracts were 
concentrated DOR, RX, and MT. Boston’s entire population by race and ethnicity ranked 
from highest to lowest prevalence was White (47%), Black (22%), Latino (17%), Asian 
(9%). (Modified from Health of Boston 2016-201711). 
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BMC has a long legacy of commitment to innovation in response to the health 
care needs of high-risk, underserved, and diverse patient populations. To accommodate 
this patient population, there are multi-lingual and multi-cultural staff, easy access to 
BMC Interpreter Services, same day visit availability, and evening and weekend hours in 
order to enable families to participate in the care of their children delivered within the 
program. BMC has also contracted with the state’s Medicaid program- MassHealth- to 
create an accountable care organization (ACO) effective March 1st, 201813.  
An ACO is a contract between a group of providers and payers that incentivizes 
providers across specialties and health care centers to have joint responsibility for a 
population of patients (Figure 3)14. Between 2010 and 2015, there has been a steady rise 
in ACO pilots by private insurers, states, Medicare, and Medicaid services; it is projected 
that by 2020, there will be 70 million people covered by an ACO15. Thus, BMC is 
aligning with the national shift from Medicaid’s traditional fee-for-service payment 
model to an ACO. An example of how the ACO improves patient care and results in 
health care savings is as follows: if a Medicaid population receives quality care resulting 
in fewer ED visits, lower admission rates, and improved medication patient self-
management, and the health care costs of the Medicaid population fall 2% or more in the 
given year, the organization will be reimbursed with the savings14,16,17. Simply, if a health 
care organization meets specific ACO quality benchmarks that focus on prevention, that 





Figure 3: What is an ACO? An ACO will connect the dots between patients and their 
providers to improve the quality of care. (Adapted from BMC16). 
 
The majority of BMC’s Pediatric Patient Population is insured through the ACO, 
but not all. The goal of BMC’s ACO is to improve patient outcomes, decrease health 
disparities, and reduce health care costs by delivering highly coordinated care for ACO-
insured patients16. As federal, hospital, and academic stakeholders invest money into 
preventive care, it is critical to ensure that people from all racial, ethnic, economic 






Statement of the Problem 
Asthma remains the most common chronic childhood illness, and there is a high 
prevalence of asthma among BMC’s pediatric primary care population. Although there 
are clear guidelines for managing pediatric asthma, the provision of guideline-based care 
and resulting patient outcomes have been historically variable. Previous studies have 
described facilitators to guideline-based care, particularly the importance of using 
validated screening tools for assessing asthma control in an outpatient setting. Although 
three versions of asthma control assessments are built into the electronic medical record 
(EMR) to record the parent and patient responses about asthma control, these tools were 
infrequently used in pediatric primary care. In December 2017, a baseline assessment 
revealed that only 8% of the time was a validated asthma control assessment 




Specific Aims and Objectives 
This thesis focuses on a quality improvement (QI) initiative to develop routine 
surveillance of asthma control for BMC’s pediatric clinic patient population in order to 
identify and intervene on patients who have poorly-controlled asthma. The specific aims 
include: 
1) To conduct a literature review of the current use of guideline-based care. 
2) To engage key stakeholders in this QI effort including physicians, nurse 
practitioners, nurses, patients and family members, an asthma program coordinator, and 
volunteer asthma educators.  
3) To use the Model for Improvement to create and track process and outcome 
measures of the QI initiative. 
4) To optimize the role of the primary care pediatricians while ensuring 
appropriate referrals to subspecialists. 





This literature review will highlight various studies using different clinical tools 
and research measures to provide insight and strategies to improve the quality of life for 
patients with asthma. First, guidelines for managing pediatric asthma will be introduced 
followed by studies that have translated the evidence-based recommendations into 
practice. 
 
Guidelines to Managing Pediatric Asthma 
The Expert Panel Report 3 (EPR–3) Full Report 2007: “Guidelines for the 
Diagnosis and Management of Asthma” was developed by the National Asthma 
Education and Prevention Program (NAEPP) and coordinated by the National Heart, 
Lung, and Blood Institute (NHLBI). These evidence-based clinical guidelines are widely 
recognized as the national standard for asthma care. The guidelines emphasize the 
importance of preventive care to close gaps in asthma care including diagnosing asthma 
in infants and young children, under-prescribing of preventive medication in all age 
groups, and variable management of children with severe, poorly controlled asthma18. 
The guidelines emphasize the importance of preventive care through four critical 
components: 1) appropriate classification of asthma severity and repeated symptom 
assessments to monitor asthma control, 2) education in conjunction with an asthma action 
plan, for patient self-management goals, 3) reducing exposures to environmental triggers 
such as indoor or outdoor allergens and irritants, and 4) to initiate and adjust long-term 
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preventive medications, such as inhaled corticosteroids, for persistent asthma 
symptoms18.  
This study will focus on the first component: classification of asthma severity and 
asthma control. First, it is crucial to differentiate asthma severity from asthma control. 
Classifications of asthma severity are: intermittent, mild persistent, moderate persistent, 
and severe persistent asthma. Clinicians determine severity for patients who do not 
currently take long-term medication by using clinical features as indicated in Table 218.  
Re-classifying severity in patients occurs when asthma becomes well controlled by the 
minimum medication required to achieve control18.  
Classifications for asthma control are well controlled, not well controlled, and 
poorly controlled. Control is achieved by a standardized approach to pharmacotherapy, 
patient education, and environmental control18. Clinicians determine control for patients 
by using most of the same clinical features of the disease process as asthma severity (see 
Table 2) with an assessment of the patient’s recall in the previous 2-4 weeks18 . Failure to 





Table 2: Features for determining Asthma Severity and Asthma Control. (Modified from 
EPR-318) 
 





and severe persistent 
asthma 
well controlled,  
not well controlled,  
and poorly controlled 
asthma 
Number of daytime versus nighttime 
symptoms 
required required 
The frequency of use of rescue 
medication for symptom control 
required required 
Level of interference with daily 
activity 
required required 
Number of exacerbations requiring 
oral systemic corticosteroids in a 
year 
required required 





It is incorrect to automatically correlate a severe persistent asthma patient with 
poorly controlled asthma, just as it is incorrect to correlate a mild persistent asthma 
patient must have well-controlled asthma; clinicians must review clinical features for 
judging each classifications19. For example, it is possible that a mild persistent asthma 
patient becomes poorly controlled when exposed to changing seasons or known triggers; 
therefore, a change in the pharmacotherapy or a modification to the environment is 
necessary to improve the control of that patient18,20. Guidelines recommend a stepwise 
approach for management according to the assessment of asthma control. When asthma is 
uncontrolled, treatment may need to be increased to the next step; by contrast, when 
asthma is controlled, a reduction in the amount of treatment may be desired18,21. 
Therefore, monitoring asthma control through repeated assessments is critical to the 
prevention of disease progression18,19. 
 
Screening for Asthma Control 
Asthma is a chronic inflammatory disorder of the airways characterized by 
symptoms including airway obstruction, bronchial hyper-responsiveness, and an 
underlying inflammation18,22. Common chronic symptoms of asthma include varied and 
recurring episodes of wheezing, breathlessness, chest tightness, and nighttime or early 
morning coughing18. These symptoms can often be controlled by avoiding or reducing 
exposure to asthma triggers and by following recommendations for appropriate medical 
care1,18,20,23. Asthma exacerbations that lead to missed school days, daily utilization of 
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rescue inhalers, ED visits, or hospital admissions are important indicators of poor asthma 
control18,24.  
There are many reasons that children with asthma have poor control of their 
symptoms and end up having exacerbations and acute health care utilization for asthma. 
The reasons include: inadequate medication prescribing, medications were prescribed but 
not obtained, families have the medications but misuse them, modifiable environmental 
triggers such as second-hand smoke and pests that are present in the home, etc18,20. The 
most important first step in addressing the causes of poor asthma control is the routine 
assessment of asthma control as indicated by the EPR-3. Several validated instruments 
have been used to assess asthma control in a variety of medical settings; the most widely 
used of these is the Asthma Control Test (ACT), a 5-7 item instrument (there are two 
versions depending on age, one for ages 4-11 years old and one for 12 years or 
older)25. The ACT includes questions about the amount of time asthma interfered with 
usual activities, the frequency of shortness of breath, nighttime symptoms, and use of 
rescue medication, and level of asthma control. For children under 4 years of age, the 
Test for Respiratory and Asthma Control in Kids (TRACK), a 5 item questionnaire, is 
often used26. The TRACK includes questions about the amount of time breathing 
problems interfered with usual activities, the frequency of breathing problems such as 
wheezing, coughing, shortness of breath, nighttime symptoms, use of rescue medication, 
and use of oral corticosteroids. These are short, patient or parent-reported screening tools 
to identify poorly controlled asthma. Low scores indicate poor asthma control. 
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Multiple studies have shown how guideline-adherent care by primary care 
physicians (PCPs) led to reduced hospitalizations, ED visits, and outpatient visits for 
children with asthma. Cloutier et al. demonstrated this following the adoption of the Easy 
Breathing™ program in urban-based clinics serving predominantly low income, minority 
children27. PCPs were more likely to adhere to national guidelines by having a validated 
survey to screen for asthma diagnosis, which led to a 25% increase in the percent of 
patients on controller medications, 27% reduction in ED visits for asthma, and 35% 
reduction in overall hospitalization rates27. The Easy Breathing program is a validated 
asthma management program to aid pediatricians in 1) diagnosing asthma, 2) classifying 
asthma severity, 3) prescribing appropriate pharmacotherapy, and 4) educating patients 
and families with a written asthma treatment plan. Through the administration of the Easy 
Breathing Survey™, a validated survey for patients written in English and Spanish in 
clinical practice, PCPs can efficiently and rapidly determine if a patient has asthma28. 
In another study, Sheikh et al. demonstrated how guideline-adherent care by 
providers had a positive effect on patient/caregiver quality of life and ACT scores over 
three years, with the most significant change between the first visit and the 3-month visit. 
This study demonstrated evidence that quality of life in caregivers of children with 
asthma improved in correlation with the children's levels of asthma control. This study 
was conducted in a pediatric pulmonary specialty clinic, where the majority of the patient 
population was Caucasian, and 24.5% Black. Although this study did not analyze health 
care utilization, improvement in quality of life survey may be a useful predictor of proper 
patient adherence to therapy and reduced health care utilization29. 
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Interventions to improve PCP adherence to the NHLBI guidelines need to focus 
not only on increasing provider knowledge but also on providing the tools for clinicians 
to effectively implement the guideline recommendations. Wisnivesky et al. demonstrated 
the lack of provider awareness in their study at three large hospital-based general 
medicine adult primary care clinics and one large community-based practice in East 
Harlem in New York, New York, where there is a predominantly Hispanic population30. 
Although 70% of providers were aware of the NHLBI guidelines, only 39% had read 
them, and 46% reported having used the guidelines to manage patients with asthma30. 
Furthermore, although 84% providers reported being able to recognize patients needing 
preventive medication (specifically the use of inhaled corticosteroids (ICS) in patients 
with mild, moderate, or severe persistent asthma), the lack of ICS use in the study per 
NHLBI recommendations was statistically correlated with lack of time during an 
encounter to prescribe and counsel patients about use30. 
The use of routine screening tools, such as the Easy Breathing™ survey and ACT, 
are effective interventions to decrease the under-diagnosis and under-treatment of 
asthma. They may also improve parent adherence through improved provider-patient 
communication. Wu et al. found that parents knew the name and frequency of prevention 
medication that the provider recommended only 50% of the time, and that parents of 
Latino children were less likely to report the child was using the same controller 
medicine as the provider prescribed. This finding is important because some Latino 
subgroups (e.g., Puerto Ricans) experience higher morbidity and mortality due to asthma 
than white children31.  
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Further contributing to the mismatch of provider-patient reports of medication use 
and to the underuse of preventive medications, a focus group conducted on PCPs from 
Boston-based community health centers reported confusion or lack of confidence about 
executing guidelines with young children, especially for children under 2 years of age.  
The documentation inconsistencies in the EMR do not accurately represent a child’s 
asthma history and can be due to diagnostic uncertainty; thus, inconsistencies can lead to 
providers giving parents mixed messages about the child’s diagnosis of asthma 
specifically with younger children. One participant provider reported,  
“For the younger kids… it’s sometimes hard for the parents to say ‘Yes, 
they have asthma.’ Maybe we told them they do maybe have it, we said 
‘reactive airway’ or something similar to it, but I feel like for those 
younger kids, a lot of the times there’s maybe a miscommunication going 
with the parents. They don’t realize that they have asthma.32”  
Childs et al. report that providers favor having a content expert come to the clinic for 
educating providers on the NAEPP guidelines to younger children, and this would 
improve the knowledge and confidence levels for PCPs32.  
 
Population Health Management 
Population health management is a strategy to deliver highly coordinated care in a 
systematic way to a population of patients; it is focused on preventive medicine and 
psychosocial determinants of health, to promote disease management, and self-care; 
ACOs are leveraging population registries to identify patients, allocate resources, close 
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gaps in care, and eliminate duplications across systems17. BMC’s current electronic 
medical record system (EMR) is EPIC™, and future developments will allow user-
capability to generate population registries, including a registry of a pediatric asthma 
population, to support the ACO goals. 
There is a delay in supporting population health across national healthcare 
organizations, despite the decades-long transition from a paper- to a technology-based 
information infrastructure33. The role of a population health registry is promotion of 
guideline-adherent care, risk stratification, and promote targeted care coordination33,34. 
The Agency for Healthcare Research and Quality (AHRQ) in the United States published 
a comprehensive user guide, and defines the role of a QI registry is to improve care:  
“it must provide actionable information for providers and/or participants 
to be able to modify their behaviors, processes, or systems of care. 
Actionable information can be provided in the form of patient outcomes 
measures (e.g., mortality, functional outcomes post discharge) or process 
of care or quality measures.35”  
In planning what the Asthma QI registry will include, it is useful also to consider 
key parameters reported in the EMR that can be pulled into the registry. Users must think 
about the types of data their organizations need, with whom they share data, and how 




“Measures are the only way we can really know if care is safe, efficient, 
effective, and patient-centered. Performance measures also help us 
improve faster. We can make corrections earlier in providing care36.”  
The National Quality Forum uses the following four criteria to determine best 
measures: 1) the measure is focused on priority areas, and thus can have a positive 
impact on health care quality, 2) the measure is scientifically acceptable, so that 
the measure when implemented will produce consistent (reliable) and credible 
(valid) results about the quality of care, 3) the measure is relevant and user-
oriented to ensure that team members can understand the results and find them 
useful for QI and decision making, and 4) the measure is easily retrievable 
without undue burden36. 
Thus, a registry is a real-time report that captures measurement and performance 
data. Opportunities exist to align EMR resources and population health management 
strategies to close the gaps between emerging demands of population health needs and 
technological capabilities29. The use of technology and registries will be insufficient 
without the right ownership and personnel to manage and promote the advancement in 
population health; the AHRQ User's Guide highlights the crucial role of QI champions:  
"Yet, the common theme for both local and national QI registries is that 
the local champions must be successful in actively engaging their 
colleagues in order for the program to go beyond an "early adopter" stage 
and be sustainable within any local organization. Once a registry matures, 
other incentives may drive participation (e.g., recognition, competition, 
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financial rewards, regulatory requirements), but the role of the champion 
in early phases cannot be overstated.35"  
With local champions to lead the work, a successful population health 
management is achieved through 1) constant surveillance of the registry, 2) opportunity 
reports, 3) acute care utilization reports, and 4) performance monitoring and reporting. 
Also, a mature Asthma QI registry would include elements to support both care delivery 
and coordination, and population measurement (Figure 4). Similar recommendations for 
overall health care information technology, including the EMR, are proposed by 
Richardson et al; they include monitoring, notifying, collaborating, reporting, and 
interoperability (Figure 537).  
Adapting the recommended framework, teams must define patient lists. A logical 
cohort for the pediatric asthma QI registry are children who have a diagnosis of asthma or 
are currently prescribed medications for asthma including rescue or preventive medicine. 
At BMC, the current version of these patient lists are named Daily Opportunity reports; 
the goal of these lists is to monitor and notify health care providers of the reason for the 
visit and to inform of acute care utilization.  
The universal themes of population health indicate that relevant and useful reports 
that are in alignment with preventive medicine in asthma, will include a list of patients: 1) 
Who need an asthma control assessment? (opportunity report) versus who had one? 
(performance), 2) Who needs ED or hospital discharge follow-up? 3) Who needs 
medication refills? 4) Who needs influenza vaccination? Another important reporting 
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measure will help identify inconsistent documentation in the EMR within the Problem 
List and Medication List. Also, through registries, population-level dashboards will 
provide a snapshot of high risk and rising risk sub-populations which will become a 
valuable decision support tool to target care to patients with “severe asthma,” low 
ACT/TRACK scores, oral corticosteroid prescriptions, and frequent urgent care visits). 
 
 





Figure 5: Recommendations for patient-centered medical home health informational 








At BMC’s Pediatric Primary Care, staff members were not screening for asthma 
control in a standardized way. A multidisciplinary Asthma QI team was created to 
develop practice improvement initiatives and receive continuous feedback on gaps 
between current care and best practice guidelines for patients with asthma. The Asthma 
QI team consisted of an asthma program coordinator and certified asthma educator, a 
PCP champion, a pulmonary pediatric physician champion who is also the content expert, 
an asthma care management nurse practitioner, and the Director of Nursing Pediatric 
Ambulatory division.  
The Institute for Healthcare Improvement’s (IHI) Model for Improvement was 
used to determine the aims of the project by addressing the following questions: 1) What 
are we trying to accomplish? 2) How will we know that a change is an improvement? 3) 
What change can we make that will result in an improvement?38. The Asthma QI team 
chose to focus on assessing asthma control for every child with asthma at every visit. 
Iterative Plan, Do, Study, Act (PDSA) cycles helped optimize results and outcome rates 
were tracked using run charts (Figure 6). To evaluate the impact of the initiative, and 
each change idea, three measures were tracked. The median was used because it is not 
affected by outliers, and the median was recalculated when there were six or more 
consecutive points either all above or all below the median. Table 3 details the aim, 
measure title, measure type, eligible patient population, numerator, denominator, data 
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source, and target rate for each measure. Qualitative data was also collected from staff 








Table 3: Proposed quantitative metrics. The process measure and two outcome measures 
were tracked on run charts to identify trends throughout the QI initiative. 
 
Measure 1 
Aim: By December 1st, 90% of the eligible population will complete the 
ACT/TRACK to assess asthma control during any type of office visit. 
Measure Title: Percent of Visits with Completed ACT/TRACK 
Measure Type: Process 
Eligible Patient 
Population 
Patients seen for an office visit for any reason in Pediatric Primary Care 
Clinics (including Adolescent Medicine and Comprehensive Care Programs) 
with either a) any diagnosis of asthma on the Problem list or b) with an active 
prescription for albuterol or levalbuterol on the medication list 
Numerator:  Number of ACT/ TRACK that is administered; measured weekly 
Denominator: Number of encounters with the eligible patient population during which an 
ACT/TRACK's should have been administered; measured weekly 
Data Source: EPIC reports; ACT/TRACK scores will be electronically entered into EPIC 
Flowsheets under 'Asthma Assessment' 
Target Rate: 90% of visit encounters 
Measure 2 
Aim: To measure the rate of low ACT/TRACK scores for BMC’s clinic population 




Measure Title: Percent of Patients with Low ACT 
Measure Type: Outcome 
Eligible Patient 
Population 
Patients seen for an office visit for any reason in Pediatric Primary Care 
Clinics (including Adolescent Medicine and Comprehensive Care Programs) 
with either a) any diagnosis of asthma on the Problem list or b) with an active 
prescription for albuterol or levalbuterol on the medication list 
Numerator:  Number of patients with a Low ACT/TRACK (ACT<20, TRACK<80); 
measured weekly 
Denominator: Number of ACT/ TRACK that is administered; measured weekly 
Data Source: EPIC reports 
Target Rate: N/A 
Measure 3 
Aim: By December 1st, 90% of the eligible population with a low ACT/TRACK 
score, indicating poor asthma control, will have a provider action performed 
and documented in the EMR to reduce impairment caused to the patient and 
reduce the risk of exacerbation.  
Measure Title: Percent of Provider Documentation of Low ACT/TRACK score 
Measure Type: Outcome 
Eligible Patient 
Population 
Patients seen for an office visit for any reason in Pediatric Primary Care 
Clinics (including Adolescent Medicine and Comprehensive Care Programs) 
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with either a) any diagnosis of asthma on the Problem list or b) with an active 
prescription for albuterol or levalbuterol on the medication list 
Numerator:  Number of patients with an intervention documented by the provider in the 
medical record. The range of interventions considered acceptable includes but 
is not limited to: assessment of barriers preventing optimal management, 
providing education about the asthma treatment plan, changing prescribed 
medications by the provider, referral for resources such as inspection for 
housing code violations and smoking cessation programs, etc. These 
interventions can be implemented by multiple members of the Pediatric 
Primary Care team including providers, nurses, navigators, health educators, 
and social workers; measured weekly 
Denominator: Number of patients with a Low ACT/TRACK (ACT<20, TRACK<80); 
measured weekly 
Data Source: Chart review in EPIC 




The first PDSA cycle was key to operationalizing the initiative. The primary 
stakeholders included 29 PCPs, 36 residents, 15 registered nurses (RN), one asthma 
program coordinator, six volunteer asthma educators, and patients and their family 
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members. In the planning phase, the Asthma QI team proposed a process map of the daily 
workflow (Figure 7). There are three timepoints involved in the process: (1) pre-visit 
planning, (2) during a patient’s clinic visit, and (3) post-visit follow-up.  
 
 
Figure 7: Process Map for ACT/TRACK screening in primary care. This map is the 
initially proposed workflow for creating a system to routinely screen for asthma control 
in the clinic. 
 
The asthma program coordinator was responsible for pulling a Daily Opportunity 
Report every morning before the start of the clinic and leaving printed copies for RNs in 
the clinic. The Daily Opportunity Report is an EPIC-generated report of patients coming 
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into primary care the same day who have albuterol or levalbuterol on the current 
medication list. These criteria were chosen because albuterol and levalbuterol are rescue 
medications for symptom control; any patient who reports frequent utilization of rescue 
medication will have poor respiratory control as indicated by EPR-3, including children 
who are not yet diagnosed with asthma.  
This report was used by RNs to anticipate which patients were to receive the 
ACT/TRACK. For eligible patients who arrive to the clinic and are on the Daily 
Opportunity Report, the RN would verbally ask the patient, parent, or guardian to answer 
the Likert scale questions on the ACT/TRACK. Simultaneously, the RN documents each 
response in EPIC. For normal scores, the visit resumes as usual. For low scores (ACT 
less than 20, or TRACK less than 80, indicating suboptimal asthma control), either the 
RN or PCP action is expected to address the patient’s self-reported uncontrolled asthma. 
A yellow sticker was initially utilized to indicate to the PCP that there was a low score. 
The RN would alert the PCP by placing the yellow sticker on the billing sheet. Upon 
completion of the encounter, one or more actions were documented into EPIC. The pilot 
of the new workflow for ACT/TRACK screening in all four primary care pediatric clinics 
(Adolescent Clinic, Pediatrics, Resident Clinic, Comprehensive Care Program) required 
multiple opportunities for hands-on education with staff in order to remove barriers for 
staff with using the EPIC Asthma Assessment and with asking the ACT/TRACK 
questions. 
Multiple, small tests of change were made following the rollout of the first PDSA 
cycle. A revised process map was created to reflect the changes that reflected best 
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practice for the asthma control assessment (Figure 8). Data was presented to all staff via 
emails every two weeks for the duration of the QI project, and monthly scheduled 
meetings with primary care staff were held to review current data trends and brainstorm 
PDSA cycles. These monthly meetings were part of an already existing staff and faculty 
meetings within the Pediatric Primary Care division.  
 
 
Figure 8: Revised Process Map for ACT/TRACK screening in primary care. The revised 
map reflects changes made after multiple PDSA cycles and is the best practice pathway 





For the PDSA cycles from June 2018 to December 2018, there was a lot of work 
to streamline the process and complete the ACT/TRACK screening for eligible patients. 
Figure 9 displays the run chart of the primary process measure for the study: percentage 
of eligible encounters with a completed ACT/TRACK during that patient visit. Following 
the implementation of routine asthma control screening in primary care, the rate of the 
process measure went from a baseline of 8% to 86%. A decrease in the median from 86% 
to 76% was mostly attributed to higher patient visit volume at the beginning of the school 
year. In July and August 2018, a median of 79 patients per week was on the Daily 
Opportunity Report; this volume increased by 25% to a median of 99 patients per week in 
September and October 2018. The volume remained steady (median of 97 patients per 
week) in November and October 2018.  
The primary care Adolescent clinic demonstrated the highest rate of 
ACT/TRACK completion; adolescent nursing staff provided feedback to other clinic 
team nurses about why the process worked for them. Suggested reasons included 1) lower 
volume of patients seen in the Adolescent clinic because of low compliance with keeping 
medical appointments, 2) usage of exam room flags to signal “RN needed,” and 3) PCPs 
filled out the ACT/TRACK if the RN was busy with another task. Other reasons for 
higher weekly rates of ACT/TRACK screening were attributed to pre-clinic huddles 




There was week-to-week variation in the ACT/TRACK completion rate, which is 
common in the QI process as refining and optimizing a new process takes time and 
involves a lot of learning. From the week of 9/24 – 10/29 there was an upward trend in 
Figure 4, with six consecutive points all going up. During this trend, two interventions 
were put into place: using translated paper copies of the ACT in Haitian Creole and 
Spanish, and creating better reports for pre-clinic huddles to allow clinicians to plan for 
the clinic session. The new Daily Opportunity Reports reflect the changed measure 
definition to exclude patients with recent ACT/TRACK scores and recent ED or hospital 
admissions for asthma.  
 
Figure 9: Run chart of ACT/TRACK completion during a patient visit. The n represents 
the number of patients on the Daily Opportunity Report per week. 
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Other interventions that facilitated this clinic-wide improvement effort are listed 
in Table 4. The first include having the asthma program coordinator provide monthly 
resident education on the process, and using EPIC schedules to identify patients needed 
to be screened. As the workflow became part of the routine primary care visit, clinicians 
discontinued the use of yellow stickers for flagging low scores since EPIC provides an 
alert of a low score on the ACT/TRACK with red font in the encounter note. Other 
interventions included offering Continuing Medical Education (CME) and Continuing 
Nursing Education (CNE) credits for physicians and RNs for their active roles in 
facilitating this ACT/TRACK project and for pursuing online training in QI 
methodology, and updating Daily Opportunity Reports to capture the targeted patient 
population including patients with a diagnosis of asthma on the problem list.   
 
Table 4: Annotations for Figure 4. Listed are the interventions and refined processes to 
the daily workflow. 
# Week Interventions and Refined Processes to Workflow 
1 1-Feb Pilot process with 3 PCPs only 
2 25-Jun Pilot new workflow for ACT/TRACK screening in all primary 
care pediatric clinics (Adolescent, Pediatrics, Resident Clinic, 
Comprehensive Care Program) 
3 9-Jul Begin Monthly Resident Education 
4 16-Jul Replace paper Daily Opportunity Reports with a yellow flag on 
the EPIC schedule 
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Discontinued yellow sticker system 
5 17-Sep Begin activities for CME/CNE credits 
Begin including Patients with “Asthma” on the problem list 
6 8-Oct Begin using translated copies of ACT (Haitian Creole/Spanish)  
Provider huddle sheets have asthma patients indicated 
7 22-Oct Update measure to exclude patients with (1) ACT/TRACK 
completed within the last four weeks of visit date, or (2) with 
recent ED visit or hospital admission for asthma 
8 3-Dec Completed activities required for earning CME/CNE credits 
 
Figure 10 displays the run chart of one of the outcome measures for the study: the 
percentage of patients with low ACT/TRACK scores. The percentage of patients with 
low scores shifted from a median of 18% to 23% when the influenza season began. There 
was an increase from a median of 15 patients per week in July-August 2018, to 19 
patients per week in September-October 2018, to 24 patients per week in November-
December 2018, indicating that there were 60% more patients requiring provider action 





Figure 10: Run chart of Patients with Low ACT/TRACK Scores. The n represents the 
number of patients with a completed ACT/TRACK score per week. 
 
Figure 11 displays the run chart of the second outcome measure for the study: 
percentage of low ACT/TRACK scores receiving provider action during the visit. The 
percentage of visits with documented provider action increased from 87% to 95% during 
this QI initiative. During the patient visit, in response to low ACT/TRACK scores, 
actions were delegated to different members of the care team. For example, PCPs used 
evidence-based guidelines to determine treatment plans and update the Asthma Action 
Plan, and RNs administered influenza vaccine. Asthma education was provided routinely 
by the PCP, RN, or asthma educator depending on staff availability during various times 
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during the clinic day. Asthma education included asthma basics, the teaching of 
differences between ICS and rescue medication, techniques for using inhaled medication 
and teach back, trigger reduction, and how to follow a written asthma action plan. The 
main goals of asthma education are to support the patient in self-management and 
adherence to the asthma action plan. 
 
 
Figure 11: Run chart of Provider Action on Low ACT/TRACK Scores during the visit. 







There are clear national guidelines for asthma disease management; however, 
there has been a gap in delivering quality care to patients with asthma especially to 
children from racial or ethnic minority groups and low-income families. Multiple factors 
are contributing to low adherence to guideline-based care including language barriers, 
variable clinician knowledge of guidelines and tools, and limitations in the EMR. This QI 
initiative demonstrates how numerous small-scale cycles accumulate into large effects on 
the quality of care received by an entire patient population. The key lessons learned are 1) 
a multidisciplinary team approach was crucial, and 2) the importance of gathering 
feedback from all members of the team for suggestions on addressing challenges and 
barriers.  
This study demonstrates the effectiveness of a process based on EPR-3 guidelines 
in identifying patients with poorly controlled asthma and reducing asthma morbidity in an 
urban-based, large, academic, pediatric primary care center. Similar to other studies, 
using a tool like the ACT or TRACK to monitor asthma control can improve diagnosis 
processes, rates of prescribed preventive pharmacotherapy, and access to patient 
education. Furthermore, the use of these guidelines can occur in a primary care setting 
rather than specialty care and will have a more significant impact on the population 
level40.  
Early challenges following clinic-wide implementation of the screening process 
included 1) testing the new process with residents, 2) motivating RNs to add this process 
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to their workload, 3) Daily Opportunity Reports were not getting printed timely, or 
printed and lost in the duration of the day, and 4) early versions of the Daily Opportunity 
Reports included only patients an active presecription for albuterol (a quick relief 
medication used for asthma) on the medication list. The PDSA analysis informed change 
ideas that led to monthly resident education, and leveraged technology for easily 
identifying patients who should be screened, ultimately expanding to capture both 
patients with asthma on the problem list and albuterol or levalbuterol on the active 
medication list. To engage PCPs and RNs, there was a friendly competition among the 
four primary care teams to determine which clinic achieved the highest rate of 
ACT/TRACK screening. Also, engagement in the QI initiative improved through 
CME/CNE activities; 18 clinicians participated and earned credits for license 
requirements. 
Initially, the process proved to be successful when it started in the summer 
months and clinic volume was lower overall. However, the most significant barrier to 
screening completion rates occurred during the Fall season, when children returned to 
school, the weather changed, the respiratory viral season began, and influenza vaccines 
became available. The fall season, epidemiologically, has a substantially increased 
frequency of asthma exacerbations in children so many more patients were presenting for 
same-day sick visits for asthma or were reporting more asthma symptoms in general 
during ACT/TRACK screening. Nurses became busier by Mid-September because they 
had to start administering influenza vaccines (which were not available over the 
summer). Nurses and providers suddenly had to address more low ACT/TRACK scores: 
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the median number of patients with low scores increased by more than 50% from July-
August to November-December. The challenge of the higher patient volume was 
addressed with exclusion criteria. Beginning the week of October 8th, 2018, the process 
measure was updated to exclude patients who completed an ACT/TRACK in the last four 
weeks or who were recently discharged from the ED or hospital admission for an asthma 
exacerbation in the last two weeks. The criteria change aligned with guidelines because 
the ACT has a four-week recall. Also, guidelines call for patients to return to primary 
care following discharges within 5-7 days, and patients with recent asthma exacerbations 
that result in ED visits or hospital admissions will automatically report poorly controlled 
asthma on the screening. Thus at the discharge follow up visits, the PCP will address the 
child’s asthma. PCPs and RNs reported some patients who were flagged for an 
ACT/TRACK did not need to be screened because these patients did not have asthma, 
although they had an albuterol prescription. This sentiment is possibly in alignment with 
current studies that show under-diagnosing of asthma or under-prescribing of ICS. 
Further work is necessary to review and update the patient problem list and medication 
lists is necessary, this can be accomplished through an asthma QI registry.  
The limitations of this project include technology needs and generalizability. The 
current EMR does not achieve the maximum capability to carry out population-based 
interventions in the ACO. There is no asthma patient registry available in EPIC, and there 
is no method of identifying at-risk patients within the targeted population. It is also 
difficult to generalize the information as this study was conducted in an urban, academic 
pediatric primary care practice with staffing variabilities such as with rotating residents 
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and traveling nurses. Therefore, consistent and timely delivery of preventive care services 
continues to be a challenge, particularly for a clinic serving high-risk, underserved, and 
culturally diverse patient populations. Table 5 summarizes the barriers and facilitators of 
success. 
Table 5: Barriers and Facilitators of Success for Implementing Routine Assessment of 
Asthma Control at BMC Pediatric Primary Care Clinic 
Barriers Facilitators 
Training concerns with rotating and 
temporary staff 
Multidisciplinary team effort  
Lack of an asthma patient registry (to 
determine “Who needs to be screened?”) 
Integrated process with EMR (ability to 
enter ACT/TRACK score, create reports, 
collect data) 
High Patient Volume during Influenza 
Season 
Language availability of screening tools 
Screening burden on staff and potentially 
patients (following discharge visits for 
asthma, recall <4 weeks) 
Collecting continuous staff feedback 
Diverse patient population Diverse patient population 
Competent documentation of asthma 
diagnosis 
Having clear national evidence-based 
guidelines (EPR-3) 
 CME/CNE availability 
 Aligned with organizations goals (ACO) 
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 Pre-clinic huddle 
 
Future Directions  
Overall, the routine screening of asthma control appeared to improve diagnostic 
processes and access to asthma education. Future directions will continue this process to 
gather and analyze better and more robust data to achieve the aim of 90%. This includes 
gathering the family perceptions of the screening, to determine if there is any burden to 
completing the ACT/TRACK in addition to other routine screenings used in primary 
care. Next steps will include a PDSA to repeat ACT/TRACK screening by phone, four 
weeks following a low score in the clinic. Alternate to phone calls, multiple studies show 
the effectiveness of web-based technology for patients to report current asthma symptoms 
and receive feedback from their care team regarding self-management41. Telehealth and 
other applications of technology for non-office based surveillance and management have 
proven effective; however, there is a gap in research on effectiveness for BMC’s patient 
population. Another PDSA can test the feasibility of screenings through secure online 
portals for enrolled patients. The overall asthma QI initiative will be shared with hospital 
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